Back to ABIVAXInsider 
Company
TRUFFLE CAPITAL SAS — ABIVAX
Filing 2023DD943554Published 21 Dec 2023France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe Pouletty, Membre du Conseil d'Administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€725,000.00
Net buy/sell
-€725,000.00
Other reported value
€0.00
Gross reported value
€725,000.00
Transactions
2
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 18 Dec 2023 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 25,000 | €9.70 | €242,500.00 | XPAR |
| 18 Dec 2023 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 50,000 | €9.65 | €482,500.00 | XPAR |
Sell
Execution date18 Dec 2023Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 25,000
- Unit price
- €9.70
- Total
- €242,500.00
Sell
Execution date18 Dec 2023Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 50,000
- Unit price
- €9.65
- Total
- €482,500.00
Evidence
- AMF · France2023DD943554
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.